Overview

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Status:
Completed
Trial end date:
2020-07-13
Target enrollment:
Participant gender:
Summary
Objective: To determine if pre-exposure prophylaxis with hydroxychloroquine is effective for the prevention of COVID-19 disease.
Phase:
Phase 3
Details
Lead Sponsor:
University of Minnesota
Treatments:
Hydroxychloroquine